Helsinn

Views & Analysis

Swiss cancer care company Helsinn has become unique in the industry by remaining a family business over three generations.

News

Shionogi has reached a $2bn agreement to buy Anglo-US biotech IntraBio and its recently approved Aqneursa therapy for two rare genetic disorders.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.